Literature DB >> 2901612

Prevention of disuse muscle atrophy by means of electrical stimulation: maintenance of protein synthesis.

J N Gibson1, K Smith, M J Rennie.   

Abstract

The effect of percutaneous electrical stimulation in preventing immobilisation-induced muscle atrophy was determined from measurements of quadriceps mass, composition, and rate of protein synthesis in seven men who had a fracture of one tibia immobilised in a long-leg cast for 6 weeks. These features were compared with those of fourteen men with similar injuries who did not use an electrical stimulator. In men who did not use the stimulator, quadriceps cross-sectional area (CSA) at midthigh, measured by ultrasonography, fell by a mean (SD) 17 (10)% and the rate of muscle protein synthesis was 23 (10)% lower on the immobilised than on the control side (0.037 [0.016] vs 0.048 [0.02]%/h). In contrast, in those who used the stimulator, quadriceps CSA (55.5 [7.3]) cm2 control leg, 50.9 [9.0] cm2 immobilised leg) and the rate of muscle protein synthesis (0.053 [0.009] %/h control leg, 0.059 [0.012] %/h immobilised leg) were similar on the two sides. The results suggest that brief periods of low-voltage percutaneous electrical stimulation will reduce quadriceps atrophy secondary to knee immobilisation, and that the mechanism includes prevention of the fall in muscle protein synthesis that usually occurs on immobilisation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2901612     DOI: 10.1016/s0140-6736(88)92417-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  50 in total

Review 1.  Physiological and methodological considerations for the use of neuromuscular electrical stimulation.

Authors:  Nicola A Maffiuletti
Journal:  Eur J Appl Physiol       Date:  2010-05-15       Impact factor: 3.078

2.  Cardiac cachexia.

Authors:  W L Morrison; R H Edwards
Journal:  BMJ       Date:  1991-02-09

3.  Letter to the Editor on the Journal Club article by Barker and Traber.

Authors:  Michael J Rennie; Philip Atherton; Anna Selby; Kenneth Smith; Marco Narici; Maarten de Boer; Stuart Phillips; Elisa Glover
Journal:  J Physiol       Date:  2007-11-08       Impact factor: 5.182

4.  Effects of chronic electrical stimulation on paralyzed expiratory muscles.

Authors:  Anthony F DiMarco; Krzysztof E Kowalski
Journal:  J Appl Physiol (1985)       Date:  2008-04-10

Review 5.  Skeletal Muscle Disuse Atrophy and the Rehabilitative Role of Protein in Recovery from Musculoskeletal Injury.

Authors:  Emily E Howard; Stefan M Pasiakos; Maya A Fussell; Nancy R Rodriguez
Journal:  Adv Nutr       Date:  2020-07-01       Impact factor: 8.701

6.  CrossTalk proposal: The dominant mechanism causing disuse muscle atrophy is decreased protein synthesis.

Authors:  Stuart M Phillips; Chris McGlory
Journal:  J Physiol       Date:  2014-12-15       Impact factor: 5.182

7.  Neuromuscular electrical stimulation for intensive care unit-acquired weakness: protocol and methodological implications for a randomized, sham-controlled, phase II trial.

Authors:  Michelle E Kho; Alexander D Truong; Roy G Brower; Jeffrey B Palmer; Eddy Fan; Jennifer M Zanni; Nancy D Ciesla; Dorianne R Feldman; Radha Korupolu; Dale M Needham
Journal:  Phys Ther       Date:  2012-03-15

8.  Tolerance and conditioning to neuro-muscular electrical stimulation within and between sessions and gender.

Authors:  Gad Alon; Gerald V Smith
Journal:  J Sports Sci Med       Date:  2005-12-01       Impact factor: 2.988

Review 9.  Combined application of neuromuscular electrical stimulation and voluntary muscular contractions.

Authors:  Thierry Paillard
Journal:  Sports Med       Date:  2008       Impact factor: 11.136

Review 10.  Physiotherapy for adult patients with critical illness: recommendations of the European Respiratory Society and European Society of Intensive Care Medicine Task Force on Physiotherapy for Critically Ill Patients.

Authors:  R Gosselink; J Bott; M Johnson; E Dean; S Nava; M Norrenberg; B Schönhofer; K Stiller; H van de Leur; J L Vincent
Journal:  Intensive Care Med       Date:  2008-02-19       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.